https://www.selleckchem.com/products/brigatinib-ap26113.html Ephedrannin B (EPB) has been shown to exert anti-inflammatory effects. However, the effect of EPB on respiratory syncytial virus infection (RSV) is not known. In this study, the cytotoxic effect of EPB was evaluated in BEAS-2B cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Reverse transcription quantitative polymerase chain reaction and Western blot assays were performed to determine the expression of target genes. The anti-viral effect of EPB was assessed by determining viral titers using plaque assay. We found that RSV infection caused a marked increase in interleukin (IL)-6, IL-8, IL-1β and tumor necrosis factor (TNF)- α production and release, which was concentration-dependently attenuated by EPB treatment. Furthermore, EPB decreased the expression of RSV fusion gene in RSV-infected BEAS-2B cells. Concomitantly, EPB treatment led to an obvious inhibition of viral replication in BEAS-2B cells. Besides, EPB suppressed RSV-induced mitogen-activated protein kinase/nuclear factor kappa-light-chainenhancer of activated B cells signaling. In conclusion, EPB exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with RSV.Pentraxin-3 (PTX3) belongs to the pentraxine family, innate immune regulators involved in angiogenesis, proliferation and immune escape in cancer. Here, we evaluated PTX3 tissue expression and serum levels as biomarkers of clear cell renal cell carcinoma (ccRCC) and analyzed the possible role of complement system activation on tumor site. A 10-year retrospective cohort study including patients undergoing nephrectomy for ccRCC was also performed. PTX3 expression was elevated in both neoplastic renal cell lines and tissues, while it was absent in both normal renal proximal tubular cells (HK2) and normal renal tissues. Analysis of complement system activation on tumor tissues showed the co-expression of PTX3 with C1q, C3aR, C5R1 and CD59, but